NCT00605267 - Arimidex/Tamoxifen Neo Adjuvant Study in Premenopausal Patients With Breast Cancer Under Anti Hormonal Treatment | Biotech Hunter

Enrollment

197

Participants

Timeline

Start Date

October 31, 2007

Primary Completion Date

November 30, 2009

Study Completion Date

December 31, 2010

Conditions

Breast Cancer

Interventions

DRUG

Tamoxifen

20 mg once daily oral dose

DRUG

Anastrazole (Arimidex)

1 mg once daily oral dose

DRUG

Goserelin acetate (Zoladex)

3.6mg/month depot injection

Trial Locations (4)

Research Site, Hakata

Research Site, Kumamoto

Research Site, Nagoya

Research Site, Osaka